Flexible Benefit Cancer Screening
Affordable access to life-saving cancer checks for your employees
Check4Cancer’s Flexible Benefit offering makes cancer screening accessible to all age-eligible employees. With fast, clinically validated screenings and expert support, you can give your workforce peace of mind and your business the benefits of a healthier team.
Because it’s always better to know.
Why offer cancer screening as a benefit?
Cancer is one of the leading health risks for UK employees. Early detection saves lives, reduces treatment burden, and shortens time away from work.
Employers who invest in preventative health see:
- Improved retention & recruitment health benefits employees genuinely value.
- Reduced absenteeism less disruption, and quicker recovery after treatment.
- Higher engagement staff feel supported and cared for.
- Controlled costs lowering claims on PMI, life assurance, and critical illness cover.
The Flexible Benefit model is now well established in the UK, with approximately one-third of employers offering such schemes, demonstrating their continued relevance and growing adoption.
Request callback
Please ensure you have read and agree to our privacy policy before submitting your request.
We can offer your employees the following Flexible Benefits
Who is it for?
MyBreastRisk is not suitable for women who have been diagnosed with breast cancer, including women with triple negative or bilateral breast cancer, and those diagnosed under age 45.
Breast SNP tests are based on a cohort of Caucasian European patients. Published data in August 2021 has confirmed breast SNP tests should not be used to predict risk in women of other ethnicities. Check4Cancer therefore only recommends our SNP test for Caucasian European ethnicities.
Why get checked?
- By performing this one-off DNA test an employee will be empowered to take control of their own breast cancer risk and ensure that they are having the most appropriate screening.
- They will be able to make lifestyle choices and behaviour changes that will protect them in the future.
How it works?
Easy to use at-home DNA testing kit that combines genetic, family history and lifestyle factors to determine a woman’s personal lifetime breast cancer risk.
- An online breast cancer risk-assessment questionnaire based on the validated Tyrer-Cuzick model*.
- Saliva DNA at-home sample collection kit.
- Once the employee has completed the sample, they simply return it in the prepaid envelope to our laboratory and will receive their results within 8 weeks.
- Results of Lifetime Risk of developing breast cancer and a personalised screening programme based on the woman’s personal risk of developing breast cancer. There are three risk categories, Average, Moderate or High Risk.
- Anyone considered to be within the ‘High Risk’ category will be offered a free genetic counselling session to discuss specific risk reduction strategies or further genetic testing.
*The Tyrer-Cuzick model, or IBIS tool, is used to estimate the likelihood of a woman developing breast cancer over the course of her lifetime.
They trusted us
We work with over 90 partners, find out who else we work with and how to partner with us
Professor Gordon Wishart
Chief Medical Officer
Professor Gordon Wishart is the founder, Chief Medical Officer and CEO of Check4Cancer, a leading early cancer detection and cancer prevention company. In 2016 Check4Cancer launched rapid access, streamlined and audited diagnostic pathways for breast and skin cancer to the insured and self-pay markets, leading to the award of “Diagnostic Provider of the Year” at the annual Health Investor Awards in 2018. In late 2017, Check4Cancer launched the first worldwide breast cancer risk test (MyBreastRisk) to combine genetic, family history and lifestyle risk factors to underpin a risk-stratified breast screening programme. As the former Director of the Cambridge Breast Unit from 2005-2010, and current Professor of Cancer Surgery at Anglia Ruskin School of Medicine since 2008, he has a strong track record in clinical research and modernisation of cancer diagnosis and treatment, with more than 100 peer-reviewed papers in scientific journals. In 2010 he led a team of clinicians and scientists that developed the PREDICT breast cancer treatment and survival model, now used worldwide.
Find out moreReviews/Testimonials
"The service was quick and efficient, it was all done online and via post. I cannot think of anything else that could be done to improve the service."
JT
"It was a very efficient and easy service, with excellent email updates throughout the process. Excellent experience as a customer."
BB
"I found the experience so much more positive than a smear test which I find embarrassing and painful. I will definitely be continuing with my screening with you as it is quick, painless, with results arriving swiftly. "
ET
"It was quick and easy and was all done in the privacy of my own home. "